Corcept Therapeutics Inc (CORT): Next-Year EPS Estimate 346.42%
As of 2026-06-04, Corcept Therapeutics Inc (CORT) has a next-year EPS growth estimate of 346.42%.
CORT was first flagged by our screen on 2026-05-27, when analyst consensus for its next-year EPS growth was revised from 234.23% to 266.23%. Since detection, the estimate has risen to 346.42% — a net gain of 80.19 percentage points across 1 upward revision. The largest single-day move came on 2026-05-28, jumping from 266.23% to 346.81% (+80.58 pp). Current-year growth is projected at -28.59%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 346.42%
- EPS growth this year
- -28.59%
- EPS next quarter (est)
- $0.01
- Last price
- $74.89
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 346.42% | -28.59% | $0.01 | $74.89 |
| 2026-06-03 | 346.42% | -28.59% | $0.01 | $72.65 |
| 2026-06-02 | 346.42% | -28.59% | $0.01 | $71.20 |
| 2026-06-01 | 346.42% | -28.59% | $0.01 | $70.44 |
| 2026-05-31 | 346.81% | -28.66% | $0.01 | $69.49 |
| 2026-05-28 | 346.81% | -28.66% | $0.01 | $68.38 |
| 2026-05-27 | 266.23% | -29.88% | $0.01 | $66.65 |
| 2026-05-26 | 234.23% | -29.88% | $0.01 | $60.36 |
| 2026-05-25 | 234.23% | -29.88% | $0.01 | $60.22 |
| 2026-05-24 | 234.23% | -29.88% | $0.01 | $60.22 |
| 2026-05-21 | 234.23% | -29.88% | $0.01 | $59.69 |
| 2026-05-20 | 234.23% | -29.88% | $0.01 | $59.06 |
| 2026-05-19 | 234.23% | -29.88% | $0.01 | $58.22 |
| 2026-05-18 | 234.23% | -29.88% | $0.01 | $55.12 |
| 2026-05-17 | 234.23% | -29.88% | $0.01 | $56.37 |
| 2026-05-14 | 234.23% | -29.88% | $0.01 | $58.30 |
| 2026-05-13 | 234.23% | -29.88% | $0.01 | $57.48 |
| 2026-05-12 | 216.96% | -38.45% | $0.01 | $51.16 |
| 2026-05-11 | 216.96% | -38.45% | $0.01 | $51.20 |
| 2026-05-10 | 216.96% | -38.45% | $0.01 | $52.28 |
| 2026-05-07 | 198.14% | -43.02% | $0.03 | $51.05 |
| 2026-05-06 | 198.14% | -43.02% | $0.03 | $52.15 |
| 2026-05-05 | 198.14% | -43.02% | $0.03 | $51.33 |
| 2026-05-04 | 198.14% | -43.02% | $0.03 | $51.60 |
| 2026-05-03 | 190.20% | -42.23% | $0.04 | $51.42 |
| 2026-04-30 | 246.59% | -54.22% | -$0.11 | $46.52 |
| 2026-04-29 | 246.59% | -54.22% | -$0.11 | $46.59 |
| 2026-04-28 | 246.59% | -54.22% | -$0.11 | $46.62 |
| 2026-04-27 | 246.10% | -54.16% | -$0.11 | $46.22 |
| 2026-04-26 | 246.10% | -54.16% | -$0.11 | $46.06 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Corcept Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Corcept Therapeutics Inc (CORT) has a next-year EPS growth estimate of 346.42%, based on analyst consensus.
When was the latest EPS estimate revision for CORT?▾
The most recent revision occurred on 2026-06-01, when analysts adjusted the next-year EPS growth estimate from 346.81% to 346.42%.
What sector and industry does Corcept Therapeutics Inc belong to?▾
Corcept Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. CORT appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Corcept Therapeutics Inc (CORT) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports